Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Weber

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Innere Medizin (Heidelberg, Germany)|February 20, 2024
[Drug-induced autoimmune-like liver injury]Sabine Weber
The American Journal of Gastroenterology|June 30, 2021
Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality AssessmentSabine Weber, Alexander L Gerbes
Digestion|January 5, 2023
Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune HepatitisSabine Weber, Alexander L Gerbes
Deutsches Arzteblatt International|February 9, 2021
Liver InvolvementAlexander L Gerbes, Sabine Weber
Hepatobiliary Surgery and Nutrition|October 27, 2023
Update on herbal and dietary supplement-induced liver injury: current gaps and future directionsSabine Weber, Alexander L Gerbes
International Journal of Molecular Sciences|June 10, 2022
Challenges and Future of Drug-Induced Liver Injury Research-Laboratory TestsSabine Weber, Alexander L Gerbes
Gut|July 27, 2022
COVID-19 and liver injury: hypoalbuminaemia and γGT should be observed at hospital admissionSabine Weber, Alexander L Gerbes
Oxford Medical Case Reports|December 3, 2020
Acute liver injury in a patient with adult-onset Still's disease-the challenge of differential diagnosisSabine Weber, Alexander L Gerbes
British Journal of Clinical Pharmacology|July 23, 2020
Further evidence for the hepatotoxic potential of metamizoleSabine Weber, Andreas Benesic, Alexander L Gerbes
Hepatology Communications|October 7, 2020
Drug-Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment ToolSabine Weber, Andreas Benesic, Masatoshi Ishigami, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Innere Medizin (Heidelberg, Germany)|February 20, 2024
[Drug-induced autoimmune-like liver injury]Sabine Weber
The American Journal of Gastroenterology|June 30, 2021
Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality AssessmentSabine Weber, Alexander L Gerbes
Digestion|January 5, 2023
Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune HepatitisSabine Weber, Alexander L Gerbes
Deutsches Arzteblatt International|February 9, 2021
Liver InvolvementAlexander L Gerbes, Sabine Weber
Hepatobiliary Surgery and Nutrition|October 27, 2023
Update on herbal and dietary supplement-induced liver injury: current gaps and future directionsSabine Weber, Alexander L Gerbes
International Journal of Molecular Sciences|June 10, 2022
Challenges and Future of Drug-Induced Liver Injury Research-Laboratory TestsSabine Weber, Alexander L Gerbes
Gut|July 27, 2022
COVID-19 and liver injury: hypoalbuminaemia and γGT should be observed at hospital admissionSabine Weber, Alexander L Gerbes
Oxford Medical Case Reports|December 3, 2020
Acute liver injury in a patient with adult-onset Still's disease-the challenge of differential diagnosisSabine Weber, Alexander L Gerbes
British Journal of Clinical Pharmacology|July 23, 2020
Further evidence for the hepatotoxic potential of metamizoleSabine Weber, Andreas Benesic, Alexander L Gerbes
Hepatology Communications|October 7, 2020
Drug-Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment ToolSabine Weber, Andreas Benesic, Masatoshi Ishigami, et al.
Pageof 6